Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Biogen Shares Soar on Landmark Alzheimer's Data | Newsmax.com
Biogen shares soar after patent victory
Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook ...
Biogen shares drop as acting FDA chief calls for probe into Alzheimer's ...
How To Buy Biogen Shares UK – With No Commission - BuyShares.co.uk
Biogen Shares Rally on Dual Clinical Breakthroughs
Biogen Shares Rise After 'Best-Case' Alzheimer's Drug Trial Results ...
Biogen shares fall after Alzheimer’s drug approval. Here’s what the ...
Biogen shares soar following promising Alzheimer's drug findings
Biogen shares soar on landmark Alzheimer's data, lift rivals | Reuters
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed ...
Biogen shares surge on upbeat Alzheimer's study results
Biogen shares plunge nearly 30% after ending trial for potential ...
Biogen Shares Explode on Talks that Company is to be Bought by Samsung ...
February 6 2026 - Biogen shares rise as Q4 earnings beat expectations ...
Biogen Shares Gain 5.5% As FDA Extends Review Period For Alzheimer’s ...
Biogen Stock Nyse / Biogen shares are plunging nearly 30% after it ...
Biogen shares jump despite mixed news on rare disease drugs - Boston ...
Biogen shares soar after US approves controversial Alzheimer’s drug
Biogen shares fall as Alzheimer's drug concerns cloud profit beat | Reuters
Biogen Shares Tumble After Discontinuing Alzheimer’s Drug - Warrior ...
Biogen Stock Quotes AI Tomorrow's Prediction ["Forecast"] Biogen Inc
Biogen Stock / Biogen Inc (BIIB) Stock Price Chart History - (biib ...
Biogen buoyed by hopes for Alzheimer’s drug
Biogen and Lilly together gain $36B in market cap : r/biotech_stocks
Biogen Stock Halted as FDA Committee Considers Alzheimer’s Drug
3 Stocks Declaring Bonus Shares and Stock Splits in May 2026
Biogen Stock: Is BIIB Underperforming the Healthcare Sector? | Nasdaq
47 Biogen Stock Stock Photos, High-Res Pictures, and Images - Getty Images
Can Biogen Stock Rebound as New Drugs Aim to Offset MS Sales Declines?
Biogen Buys Reata Pharmaceuticals, Expanding Its Lineup of Rare Disease ...
Biogen Stock Forecast - pretiming: BIIB. Daily (Biogen Idec Inc.) BIIB ...
Biogen (BIIB) Stock Rallied 53% on Alzheimer’s Drug Trial Results
Biogen Stock Forecast: Where Analysts See the Stock Going by 2027 ...
Is Biogen Stock a Buy Now? | The Motley Fool
Biogen Stock Jumps On Report Of Interest From Merck, Allergan – SGEIZ
Biogen Stock Jumps After Announcing $5 Billion Share Buyback - Barron's
Buy Biogen Stock Now Because Its Alzheimer Drug Has a ‘Decent Shot’ at ...
William Blair Issues Negative Forecast for Biogen Earnings
Biogen Buys Biotech Firm HI-Bio to Boost Its Immunology Portfolio
Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid
Biogen Stock: Cheapish, But With Few Growth Prospects (NASDAQ:BIIB ...
Biogen Is Skyrocketing After Its Alzheimer's Drug Delivers Positive ...
Biogen Total Revenue
Here's Why 275% in Biogen Inc Stock Looks Realistic | InvestorPlace
FinancialContent - Biogen Stock: Is BIIB Outperforming the Healthcare ...
Biogen Inc. Interactive Stock Chart – IRYRK
Biogen ahead of Q1 earnings 📊Patient Capital sees opportunity in ...
Biogen stock gains on upbeat Q2 results - Alphastreet
Biogen Stock Surges After Alzheimer's Approval
Biogen Inc. (NASDAQ:BIIB) Faces Mixed Financial Results Amidst ...
Biogen Stock Price Today | NASDAQ: BIIB Live - Investing.com
Biogen Stock Is Near a Multiyear Low. The CEO and a Hedge Fund Bought ...
Biogen stock opened higher on positive lupus readout By Investing.com
Biogen Stock: Is BIIB Outperforming the Healthcare Sector?
What Are Wall Street Analysts' Target Price for Biogen Stock?
Biogen stock Forecast for 2022 and 2023 - FOREX24.PRO
Biogen Stock India / Eisai and Biogen to move forward with Alzheimer's ...
Biogen Stock (BIIB) Offers a Decent Trend Trading Opportunity
Biogen Stock Clings to Key Level After Explosive Rally - TheStreet
Biogen Stock Could Have Run Up Too Far on Alzheimer’s Drug Revival ...
Biogen Tumbles as Drug Closeout Costs, Multiple Sclerosis Medicine ...
Is Biogen Stock a Buy? | The Motley Fool
Biogen Stock Outlook: Is Wall Street Bullish or Bearish? | Nasdaq
How to Buy Biogen Stock | Invest in BIIB
Biogen Pharma Share Analysis • Biogen Pharma Breaking News • Dailystock ...
Driven by Leqembi, Biogen beats Q2 expectations, raises full-year outlook
This Biogen Partnership May Save Your Life | The Mad Hedge Fund Trader
Biogen Surges as New Alzheimer's and Rare-Disease Drugs Drive Profit ...
Biogen (BIIB) Reports Q4: Everything You Need To Know Ahead Of Earnings ...
Biogen Stock Price Falls 32% As Alzheimer's Therapy Fails to Win FDA ...
Biogen stock at lowest level since February 2013 following J.P. Morgan ...
With an Acquisition on the Way, Is Biogen Stock a Buy? | The Motley Fool
Biogen Stock Performance 2026 | Financial Results & Analyst Ratings ...
Can Biogen Regain Its Mojo? BIIB Earnings On Tap...
Biogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm | Nasdaq
Biogen Stock Climbs After a Presentation at an Alzheimer’s Conference ...
Biogen (NASDAQ:BIIB) Rolls out Another New Treatment - TipRanks.com
Biogen tops quarterly profit estimates, eyes deals to build early-stage ...
Biogen Stock Moves Lower Despite Beat-and-Raise
FDA Approves New Alzheimer's Drug But Creators Biogen And Eisai Stock ...
Biogen Stock Strikes Out With Investors Over ALS Drug Pipeline - Barron's
Biogen Stock Drops Premarket
Biogen (BIIB) Stock Is Evolving into a Strong Value Play
After Rallying 50% in the Last 2 Months, Is Biogen Stock Still a Buy ...
As Biogen Stock Struggles, Look Elsewhere for Biotech Exposure ...
Biogen (BIIB) Stock Rally Erases 2019 Alzheimer's Drug Struggle - Bloomberg
Biogen Stock Surges After Study Shows Its Alzheimer’s Drug Slows ...
Biogen Stock Soars on Return of Alzheimer’s Drug - Barron's
Which Funds Got the Biggest Biogen Boost? | Morningstar
Biogen Stock Price : 7e6xlrjvgx Jsm - This price target is based on 31 ...
Biotech’s Turning Up… | Internet | Biotech Stock Review
What to Expect From Biogen’s Q3 2025 Earnings Report
Here's What to Expect From Biogen's Next Earnings Report
Is Biogen's Stock Too Risky to Invest in? | The Motley Fool
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results - Alphastreet
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue ...
Biogen's new Alzheimer's drug slows cognitive decline: study - Boston ...
Biotech Stocks Keep Falling on Good News. What's Behind the Phenomenon ...
2025 Profit Forecast: Biogen's 2025 forecasts hit by declining sales ...
Biogen’s stock bounces after FDA boost on kidney-transplant rejection ...
Understanding the impact of Biogen's strategic job cuts
How Is Biogen's Stock Performance Compared to Other Biotech Stocks ...
Biogen, PayPal, Block, Ally Financial: What to Watch in the Stock ...
Biogen’s Huge Discovery